PDCD1 and cancer: In recent years, various different inhibitory immuno-receptors, also known as immune checkpoints, have been identified and analyzed for their role in cancer, including but not limited to PD-1, CTLA-4, LAG3, TIM3, TIGIT, and BTLA (summarized in Figure 1).